Bell Investment Advisors’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.72K | Buy |
123
+71
| +137% | +$993 | ﹤0.01% | 1406 |
|
|
2025
Q1 | $707 | Hold |
52
| – | – | ﹤0.01% | 1656 |
|
|
2024
Q4 | $1.06K | Hold |
52
| – | – | ﹤0.01% | 1561 |
|
|
2024
Q3 | $1.52K | Hold |
52
| – | – | ﹤0.01% | 1457 |
|
|
2024
Q2 | $1.21K | Hold |
52
| – | – | ﹤0.01% | 1553 |
|
|
2024
Q1 | $1.07K | Sell |
52
-25
| -32% | -$513 | ﹤0.01% | 1586 |
|
|
2023
Q4 | $1.65K | Buy |
77
+34
| +79% | +$730 | ﹤0.01% | 1413 |
|
|
2023
Q3 | $888 | Sell |
43
-21
| -33% | -$434 | ﹤0.01% | 1614 |
|
|
2023
Q2 | $1.89K | Hold |
64
| – | – | ﹤0.01% | 1329 |
|
|
2023
Q1 | $1.48K | Hold |
64
| – | – | ﹤0.01% | 1406 |
|
|
2022
Q4 | $1.78K | Hold |
64
| – | – | ﹤0.01% | 1352 |
|
|
2022
Q3 | $2K | Hold |
64
| – | – | ﹤0.01% | 1080 |
|
|
2022
Q2 | $2K | Buy |
+64
| New | +$2K | ﹤0.01% | 1127 |
|
|
2021
Q4 | $0 | Sell |
11
-13
| -54% | – | ﹤0.01% | 1814 |
|
|
2021
Q3 | $1K | Buy |
+24
| New | +$1K | ﹤0.01% | 1345 |
|